Dare Bioscience (DARE) Earnings Analysis

Dare Bioscience (DARE) next reports earnings on 2026-08-13, consensus EPS -0.33 USD. Last quarter (2026-05-14) it beat with EPS -0.2 USD vs -0.33 USD est (+39.4%). It has beaten estimates in 7/7 recent quarters (100%). Trailing P/E -1.17.

Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades

When does DARE next report earnings?

Next earnings date2026-08-13
Consensus EPS estimate-0.33 USD
Revenue estimate0.00B

DARE earnings history — beats and misses

Quarter (report date)EPS actualEPS est.SurpriseResult
2026-05-14-0.2 USD-0.33 USD+39.4%Beat
2026-03-26-0.02 USD-0.24 USD+91.7%Beat
2025-11-13-0.28 USD-0.33 USD+15.2%Beat
2025-08-14-0.45 USD-0.55 USD+18.2%Beat
2025-03-31-0.64 USD-0.66 USD+3%Beat
2024-11-14-0.55 USD-0.6 USD+8.3%Beat
2024-08-121.52 USD-0.57 USD+366.7%Beat

Beat rate: 7/7 (100%) over reported quarters with consensus data.

DARE valuation and analyst view

Trailing P/E-1.17
Trailing EPS-0.82772 USD
Price / book24.12
Dividend yield0.00%
Market cap0.01B
Analyst consensusBuy (6 buy / 0 hold / 0 sell)

Related research pages

Frequently asked questions

When is Dare Bioscience (DARE)'s next earnings date?

Dare Bioscience is next scheduled to report on 2026-08-13, with a consensus EPS estimate of -0.33 USD and revenue estimate of 0.00B.

Did DARE beat earnings last quarter?

In its 2026-05-14 report, DARE posted EPS of -0.2 USD versus a -0.33 USD estimate — a beat of 39.4%.

What is DARE's earnings track record?

Over the last 7 reported quarters with consensus data, DARE beat estimates 7 times (100%).

What is DARE's current P/E ratio and EPS?

DARE trades at a trailing P/E of -1.17 on trailing EPS of -0.8277210338064159 USD.

What do analysts rate DARE?

Analyst consensus is "Buy" across 6 ratings (0 strong buy, 6 buy, 0 hold, 0 sell, 0 strong sell).